Meeting Coverage:

American Academy of Ophthalmology

AAO: 2021

Top-Line Results from DERBY and OAKS—the Good and the Bad

Show Description +

Charles C. Wykoff, MD, PhD, details treatment safety and efficacy of pegcetacoplan, including a reduced rate of GA growth and safety signals of intraocular inflammation and new-onset exudation.

Posted: 11/17/2021

Top-Line Results from DERBY and OAKS—the Good and the Bad

Charles C. Wykoff, MD, PhD, details treatment safety and efficacy of pegcetacoplan, including a reduced rate of GA growth and safety signals of intraocular inflammation and new-onset exudation.

Posted: 11/17/2021


Please log in to leave a comment.